Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark

Benedikt Fischer; Didier Jutras-Aswad; Wayne Hall

doi:10.1503/cmaj.230808

Article Information

vol. 195 no. 39 E1351-E1353

DOI

https://doi.org/10.1503/cmaj.230808

PubMed

37816520

History

Published online October 9, 2023.

© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Benedikt Fischer, PhD,
Didier Jutras-Aswad, MD MSc,
Wayne Hall, PhD

Centre for Applied Research in Mental Health and Addiction (Fischer), Faculty of Health Sciences, Simon Fraser University, Vancouver, BC; Division of Research and Graduate Studies (Fischer), University of the Fraser Valley, Abbotsford, BC; Department of Psychiatry (Fischer), University of Toronto, Toronto, Ont.; School of Population Health (Fischer), University of Auckland, Auckland, New Zealand; Department of Psychiatry (Fischer), Federal University of Sao Paulo, São Paulo, Brazil; Department of Psychiatry and Addictology (Jutras-Aswad), Université de Montréal; Research Centre of the Centre Hospitalier de l’Université de Montréal (CRCHUM) (Jutras-Aswad), Montréal, Que.; National Centre for Youth Substance Use Research (Hall), Faculty of Health and Behavioural Sciences, University of Queensland, St Lucia, Australia.